Stock Updates

A look at a High Market Cap Stock: AmerisourceBergen Corporation, ABC

AmerisourceBergen Corporation, ABC is in the exchange NYSE and its industry is Drugs Wholesale in the sector of Services. Based in USA, AmerisourceBergen Corporation, ABC  has a market cap of 19005.62. Since its IPO date on the 4/4/1995, AmerisourceBergen Corporation, ABC performance year to date is -13.72%. Today AmerisourceBergen Corporation, ABC has gained -1.99%, with a current price of 86.63.

Ownership of the company is 0.30% for insider ownership while institutional ownership is 76.40%. The management of the company have seen the company have a payout ratio of 16.70%. Return of assets are at 5.40%, with return on investment at -0.50%.

In terms of debt levels and profit levels, AmerisourceBergen Corporation, ABC is seeing a long-term debt/equity of 2.02. While Total debt/equity is 2.35. With a profit margin of 1.10%, this is combined with a gross margin of 2.90%, and operating margin of 1.20%. AmerisourceBergen Corporation ability to meet debt levels, with a current ratio of 0.9, while the quick ratio is 0.5.

For the last year AmerisourceBergen Corporation, ABC has seen a EPS growth of -151.30%. A performance for the year of -7.82%. The 52-week high is -18.65%, and the 52-week low is 18.79%. The average volume for AmerisourceBergen Corporation, ABC is 1441825.

With a target price of 92.82, can AmerisourceBergen Corporation, ABC reach this target? Looking at the value indicators of AmerisourceBergen Corporation, ABC. AmerisourceBergen Corporation has a P/E of 11.92 and a forward P/E of 15.14. Perhaps the more useful indicator than P/E, is PEG which has a value of 1.25. AmerisourceBergen Corporation also has a P/S and a P/B of 0.13 and 10.15 respectively. For P/cash, AmerisourceBergen Corporation has a value of 10.19, while it is 8.19 for P/free cash flow.

At the current price of 86.63, AmerisourceBergen Corporation has a dividend yield of 1.54%. We see a return on equity of 109.80%.

Looking more long-term AmerisourceBergen Corporation, is projected to get an EPS growth for the next five years of 9.54%. In the short-term an EPS growth of 5.07% in the next year is forecasted. This is after a EPS growth of -151.30% for this year and for the last five years a -17.90% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment